Loading...
Liraglutide
India Pharmaceutical Trade Intelligence
Who Supplies Liraglutide to India from DENMARK
India's liraglutide imports from DENMARK total $157.8M across 23 shipments from 5 foreign suppliers. M S NOVO NORDISK A S leads with $121.9M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include NOVO NORDISK INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for liraglutide — a diversified sourcing base with multiple active suppliers from DENMARK.
Top foreign suppliers (DENMARK) — Ranked by import value
M S NOVO NORDISK A S is the leading Liraglutide supplier from DENMARK to India, with import value of $121.9M across 4 shipments. The top 5 suppliers — M S NOVO NORDISK A S, M/S. NOVO NORDISK A/S, MS NOVO NORDISK A/S, RX SOURCE LIMITED, E-PHARM LIMITED — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (DENMARK)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M S NOVO NORDISK A S | $121.9M | 4 | 77.2% |
| 2 | M/S. NOVO NORDISK A/S | $35.1M | 11 | 22.3% |
| 3 | MS NOVO NORDISK A/S | $796.8K | 3 | 0.5% |
| 4 | RX SOURCE LIMITED | $10.8K | 2 | 0.0% |
| 5 | E-PHARM LIMITED | $4.4K | 3 | 0.0% |
Showing top 5 of 5 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from DENMARK)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVO NORDISK INDIA PRIVATE LIMITED | $157.8M | 18 | 100.0% |
| 2 | BIOLOGICAL E. LIMITED | $10.8K | 2 | 0.0% |
| 3 | DR.REDDY'S LABORATORIES LTD | $4.4K | 3 | 0.0% |
Import Statistics
- Import Value
- $157.8M
- Shipments
- 23
- Foreign Suppliers
- 5
- Indian Buyers
- 3
- Avg. Shipment
- $6.9M
Other Liraglutide Import Origins
Related Analysis
Frequently Asked Questions — Liraglutide Imports from DENMARK
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Liraglutide suppliers from DENMARK to India?
The top Liraglutide suppliers from DENMARK to India include M S NOVO NORDISK A S, M/S. NOVO NORDISK A/S, MS NOVO NORDISK A/S. The leading supplier is M S NOVO NORDISK A S with import value of $121.9M USD across 4 shipments. India imported Liraglutide worth $157.8M USD from DENMARK in total across 23 shipments.
QHow much Liraglutide does India import from DENMARK?
India imported Liraglutide worth $157.8M USD from DENMARK across 23 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Liraglutide from DENMARK?
The main Indian buyers of Liraglutide sourced from DENMARK include NOVO NORDISK INDIA PRIVATE LIMITED, BIOLOGICAL E. LIMITED, DR.REDDY'S LABORATORIES LTD. The largest buyer is NOVO NORDISK INDIA PRIVATE LIMITED with $157.8M in imports across 18 shipments.
QWhat is the total value of Liraglutide imports from DENMARK to India?
The total value of Liraglutide imports from DENMARK to India is $157.8M USD, across 23 shipments and 5 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: DENMARK to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Liraglutide.
- 2.Supplier/Buyer Matching: 5 foreign suppliers from DENMARK and 3 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $157.8M aggregated from 23 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
23 Verified Shipments
5 suppliers, 3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists